CD40 pathway blockade as an approach to immunotherapy

Adv Exp Med Biol. 2001;489:135-52. doi: 10.1007/978-1-4615-1277-6_12.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use*
  • Antigen Presentation
  • Antigen-Presenting Cells / immunology
  • Arteriosclerosis / immunology
  • Arteriosclerosis / therapy
  • Autoimmune Diseases / immunology
  • Autoimmune Diseases / therapy
  • CD40 Antigens / genetics
  • CD40 Antigens / immunology
  • CD40 Ligand / genetics
  • CD40 Ligand / immunology*
  • CD40 Ligand / physiology
  • Cell Adhesion Molecules / biosynthesis
  • Cell Adhesion Molecules / genetics
  • Cell Communication / immunology
  • Chemotaxis / physiology
  • Disease Models, Animal
  • Encephalomyelitis, Autoimmune, Experimental / immunology
  • Encephalomyelitis, Autoimmune, Experimental / therapy
  • Gene Expression Regulation
  • Graft Rejection / prevention & control
  • Hematopoietic Stem Cells / cytology
  • Hematopoietic Stem Cells / immunology
  • Humans
  • Immunotherapy / methods*
  • Lymphocyte Activation / immunology
  • Lymphocyte Cooperation / immunology*
  • Macaca fascicularis
  • Mice
  • Models, Immunological
  • Multigene Family
  • Pulmonary Fibrosis / immunology
  • Pulmonary Fibrosis / therapy
  • Receptors, Antigen, T-Cell / immunology
  • Stromal Cells / cytology
  • Stromal Cells / immunology
  • T-Lymphocytes, Helper-Inducer / immunology
  • Virus Diseases / immunology

Substances

  • Antibodies, Monoclonal
  • CD40 Antigens
  • Cell Adhesion Molecules
  • Receptors, Antigen, T-Cell
  • CD40 Ligand